Identification of evolutionary mechanisms of myelomatous effusion by single-cell RNA sequencing

被引:10
作者
Sun, Zhengxu [1 ]
Ji, Jiamei [1 ]
Li, Yating [1 ]
Cui, Yunqi [1 ]
Fan, Lei [1 ]
Li, Jianyong [1 ]
Qu, Xiaoyan [1 ]
机构
[1] Nanjing Med Univ, Jiangsu Prov Hosp, Dept Hematol, Affiliated Hosp 1, 300 Guangzhou Rd, Nanjing 210029, Peoples R China
基金
中国国家自然科学基金;
关键词
PLEURAL EFFUSION; MULTIPLE-MYELOMA; EXTRAMEDULLARY DISEASE; TUMOR HETEROGENEITY; ASCITES;
D O I
10.1182/bloodadvances.2022009477
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myelomatous effusion (ME) is a rare manifestation of extramedullary multiple myeloma (MM) with limited therapeutic options and poor outcomes. The molecular mechanisms underlying ME are incompletely understood. We profiled transcriptomes of bone marrow, peripheral blood (PB), and pleural effusion/ascites from 3 patients with ME using single-cell RNA sequencing analysis. We found that ME contained a higher percentage of cytotoxic T cells, whereas PB contained a higher proportion of naive T cells. Malignant cells varied within and between sites and patients in their expression of signatures. We identified a gene module highly expressed in intramedullary and extramedullary plasma cell clusters and defined cell clusters expressing this gene set as extramedullary-initiating cells (EMICs). This gene set was associated with increased cellular proliferation, involved in p53 signaling, and related to poor prognosis in MM. The transcriptional regulators E2F1, YY1, and SMAD1 were activated in EMICs. Leukocyte immunoglobulin-like receptor subfamily B4 (LILRB4) was upregulated in extramedullary EMICs. We confirmed that LILRB4 promoted MM cell migration in vitro. This study provided insight into the evolutionary mechanisms of ME and defined EMICs and LILRB4 associated with extramedullary development.
引用
收藏
页码:4148 / 4159
页数:12
相关论文
共 54 条
[1]   Concise Review: Defining and Targeting Myeloma Stem Cell-Like Cells [J].
Abe, Masahiro ;
Harada, Takeshi ;
Matsumoto, Toshio .
STEM CELLS, 2014, 32 (05) :1067-1073
[2]   UCell: Robust and scalable single-cell gene signature scoring [J].
Andreatta, Massimo ;
Carmona, Santiago J. .
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 :3796-3798
[3]   A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome [J].
Beksac, Meral ;
Seval, Guldane Cengiz ;
Kanellias, Nicholas ;
Coriu, Daniel ;
Rosinol, Laura ;
Ozet, Gulsum ;
Goranova-Marinova, Vesselina ;
Unal, Ali ;
Bila, Jelena ;
Ozsan, Hayri ;
Ivanaj, Arben ;
Balic, Lejla Ibricevic ;
Kastritis, Efstathios ;
Blade, Joan ;
Dimopoulos, Meletios Athanasios .
HAEMATOLOGICA, 2020, 105 (01) :201-208
[4]   Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma [J].
Bergsagel, PL ;
Kuehl, WM ;
Zhan, FH ;
Sawyer, J ;
Barlogie, B ;
Shaughnessy, J .
BLOOD, 2005, 106 (01) :296-303
[5]   Extramedullary multiple myeloma [J].
Bhutani, Manisha ;
Foureau, David M. ;
Atrash, Shebli ;
Voorhees, Peter M. ;
Usmani, Saad Z. .
LEUKEMIA, 2020, 34 (01) :1-20
[6]   Pleural Effusion in Multiple Myeloma: Characteristics and Practice Patterns [J].
Byun, Ja Min ;
Kim, Ki Hwan ;
Choi, In Sil ;
Park, Jin Hyun ;
Kim, Jin-Soo ;
Shin, Dong-Yeop ;
Koh, Youngil ;
Kim, Inho ;
Yoon, Sung-Soo ;
Lim, Hyo Jeong .
ACTA HAEMATOLOGICA, 2017, 138 (02) :69-76
[7]   METTL3 facilitates multiple myeloma tumorigenesis by enhancing YY1 stability and pri-microRNA-27 maturation in m6A-dependent manner [J].
Che, Feifei ;
Ye, Xuemei ;
Wang, Yu ;
Wang, Xuemei ;
Ma, Shuyue ;
Tan, Yawen ;
Mao, Yan ;
Luo, Ziyue .
CELL BIOLOGY AND TOXICOLOGY, 2023, 39 (05) :2033-2050
[8]   Tumour heterogeneity and resistance to cancer therapies [J].
Dagogo-Jack, Ibiayi ;
Shaw, Alice T. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (02) :81-94
[9]   Efficacy of Humanized Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With and Without Extramedullary Disease [J].
Deng, Haobin ;
Liu, Meijing ;
Yuan, Ting ;
Zhang, Huan ;
Cui, Rui ;
Li, Jingyi ;
Yuan, Jijun ;
Wang, Xiaofang ;
Wang, Yafei ;
Deng, Qi .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[10]   LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration [J].
Deng, Mi ;
Gui, Xun ;
Kim, Jaehyup ;
Xie, Li ;
Chen, Weina ;
Li, Zunling ;
He, Licai ;
Chen, Yuanzhi ;
Chen, Heyu ;
Luo, Weiguang ;
Lu, Zhigang ;
Xie, Jingjing ;
Churchill, Hywyn ;
Xu, Yixiang ;
Zhou, Zhan ;
Wu, Guojin ;
Yu, Chenyi ;
John, Samuel ;
Hirayasu, Kouyuki ;
Nam Nguyen ;
Liu, Xiaoye ;
Huang, Fangfang ;
Li, Leike ;
Deng, Hui ;
Tang, Haidong ;
Sadek, Ali H. ;
Zhang, Lingbo ;
Huang, Tao ;
Zou, Yizhou ;
Chen, Benjamin ;
Zhu, Hong ;
Arase, Hisashi ;
Xia, Ningshao ;
Jiang, Youxing ;
Collins, Robert ;
You, M. James ;
Homsi, Jade ;
Unni, Nisha ;
Lewis, Cheryl ;
Chen, Guo-Qiang ;
Fu, Yang-Xin ;
Liao, X. Charlene ;
An, Zhiqiang ;
Zheng, Junke ;
Zhang, Ningyan ;
Zhang, Cheng Cheng .
NATURE, 2018, 562 (7728) :605-+